DIAGNOS (DGNOF) Stock Price, News & Analysis

Company Overview

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Key Stats

• Today's Range: $0.24 to $0.26
• 50-Day Range: $0.20 to $0.26
• 52-Week Range: $0.17 to $0.31
• Volume: 86,062 shs
• Average Volume: 100,506 shs
• Market Capitalization: $24.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DGNOF Stock Analysis - Frequently Asked Questions

How have DGNOF shares performed this year?

DIAGNOS's stock was trading at $0.1950 at the beginning of the year. Since then, DGNOF stock has increased by 25.5% and is now trading at $0.2448.
View the best growth stocks for 2025 here.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (OTCMKTS:DGNOF) released its earnings results on Wednesday, February, 12th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of DIAGNOS?

Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/12/2025
• Today: 2/22/2025
• Next Earnings (Estimated): 2/26/2025
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Private households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DGNOF
• CUSIP: N/A
• CIK: N/A
• Web: www.diagnos.ca
• Phone: (450) 678-8882
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,310,000.00
• Net Margins: -2,912.77%
• Pretax Margin: -2,423.01%
• Return on Equity: N/A
• Return on Assets: -242.73%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.09
• Quick Ratio: 1.09

Sales & Book Value

• Annual Sales: $130,000.00
• Price / Sales: 190.34
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -8.16

Miscellaneous

• Outstanding Shares: 101,080,000
• Free Float: N/A
• Market Cap: $24.74 million
• Optionable: Not Optionable
• Beta: 0.11